CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy

BACKGROUND: Identifying response markers is highly needed to guide the treatment strategy in patients with metastatic melanoma. METHODS: A retrospective study was carried out in patients with unresectable/metastatic melanoma (stage IIIb–IV), treated with anti-PD-1 in the first line setting, to bette...

Descripción completa

Detalles Bibliográficos
Autores principales: Mallardo, Domenico, Fordellone, Mario, White, Andrew, Ottaviano, Margaret, Sparano, Francesca, Bailey, Michael, Facchini, Arianna Bianca, Ong, Sufey, Maiolino, Piera, Caracò, Corrado, Church, Sarah, Cavalcanti, Ernesta, Warren, Sarah, Budillon, Alfredo, Cesano, Alessandra, Simeone, Ester, Chiodini, Paolo, Ascierto, Paolo Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492378/
https://www.ncbi.nlm.nih.gov/pubmed/37684649
http://dx.doi.org/10.1186/s12967-023-04419-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492378/
https://www.ncbi.nlm.nih.gov/pubmed/37684649
http://dx.doi.org/10.1186/s12967-023-04419-6

Ejemplares similares